Equities

AK Medical Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

AK Medical Holdings Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)6.15
  • Today's Change-0.02 / -0.32%
  • Shares traded2.43m
  • 1 Year change+20.59%
  • Beta0.4439
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

AK Medical Holdings Ltd is a company mainly engaged in the production and sale of bone and joint implants, spinal implants, trauma implants and a full range of surgical instruments. The Company's main products and services fall into four categories. The hip and knee replacement implant products include knee replacement implants and hip replacement implants, as well as three-dimensional (3D)-printed hip and knee replacement implants. The spinal and trauma implant products of the Group include traditional spinal implants and trauma implants, as well as 3D-printed spinal implants. The digital orthopedics customised products and services include customised joint, pelvic, spinal and trauma implant products and customised value-added surgical services and Visual Treatment Solution (VTS) Navigation System. The Others include surgical instruments and third party orthopedic products.

  • Revenue in HKD (TTM)1.57bn
  • Net income in HKD334.06m
  • Incorporated2015
  • Employees1.00k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Peijia Medical Ltd755.33m-254.75m4.12bn1.04k--1.84--5.45-0.3851-0.38511.143.330.25611.4017.04721,424.50-8.76-26.57-10.02-28.9969.2571.23-34.21-247.651.49-15.300.1396--39.53101.1342.28--83.33--
Acotec Scientific Holdings Ltd670.70m114.15m4.32bn645.0036.802.6424.846.440.37440.37442.235.210.33531.063.531,031,848.005.710.24676.450.28975.2381.3317.020.71225.57--0.14060.0012.6933.72260.8817.7483.44--
MicroPort CardioFlow Medtech Corp415.79m5.49m5.41bn417.00361.220.830650.3113.020.00240.00240.17851.020.14231.001.77966,955.600.0886-13.380.0996-16.8469.0864.410.6228-124.496.50--0.112--7.5475.8589.51--26.60--
Modern Dental Group Ltd3.50bn478.00m5.47bn8.59k11.491.838.761.560.50930.50933.733.190.82979.044.89492,119.5011.428.0813.349.6054.0651.8513.7610.322.7654.800.199940.786.056.990.965120.360.4449--
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd624.77m325.09m5.73bn374.0017.632.5716.039.170.93750.93751.806.440.24940.83236.061,989,699.0012.987.8314.899.2887.2389.1852.0335.625.03--0.000681.7844.4032.2862.2236.4582.59--
Yidu Tech Inc841.28m-100.62m6.30bn823.00--1.45--7.48-0.0953-0.09530.79534.120.159524.781.341,022,216.00-2.03-24.00-2.38-30.0834.4135.64-12.72-123.004.37--0.0321---11.415.0839.58--26.45--
Shanghai INT Medical Instruments Co Ltd1.04bn202.40m6.54bn2.01k25.672.5721.156.281.211.216.2212.060.38022.0511.49600,349.607.988.4610.149.8160.9960.3421.0024.360.96626.740.225324.3113.1724.3615.6312.6817.46--
China Isotope & Radiation Corp8.62bn479.84m6.56bn3.36k13.681.145.010.76121.501.5026.9617.970.51863.141.752,561,072.006.226.3112.9912.9948.2655.5411.9911.951.5168.900.27530.1614.1613.689.624.3311.8123.56
BrainAurora Medical Technology Ltd192.86m-237.94m6.61bn174.00--22.03--34.30-0.1879-0.18790.15230.22110.3274--1.241,212,958.00-40.54---112.29--41.26---123.83-----10.130.6324--82.01--44.78------
MicroPort NeuroScientific Corp833.17m230.32m6.86bn522.0029.853.5123.168.230.3990.3991.443.400.35431.293.101,580,970.009.696.0411.237.0173.5874.5827.3616.604.71142.060.014135.6914.4432.9074.6340.172.49--
AK Medical Holdings Ltd1.57bn334.06m6.91bn1.00k20.612.2315.154.420.29840.29841.402.750.4111.062.661,640,641.008.778.0110.899.6959.2763.0121.3420.182.88--0.074722.5723.087.7650.420.51418.660.1873
Zylox-Tonbridge Medical Technolgy Co Ltd1.02bn172.63m7.89bn875.0044.022.1036.827.760.53160.53163.1411.120.25731.40425.711,161,637.004.37-3.214.84-3.4471.4772.7516.98-21.205.16--0.0257--48.27175.65227.34--35.70--
LifeTech Scientific Corp1.50bn81.35m7.92bn1.27k91.391.8667.325.270.01870.01870.34570.92090.26150.69758.111,078,952.000.48166.080.58227.2672.6078.531.8420.722.09--0.13080.002.8814.28-15.5211.4715.11--
Data as of Feb 16 2026. Currency figures normalised to AK Medical Holdings Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

18.55%Per cent of shares held by top holders
HolderShares% Held
Platinum Investment Management Ltd.as of 26 Feb 202555.90m4.97%
HHLR Advisors Ltd.as of 22 Oct 202454.90m4.89%
The Vanguard Group, Inc.as of 04 Feb 202621.77m1.94%
Fidelity Management & Research (Hong Kong) Ltd.as of 31 Dec 202517.16m1.53%
UBS Asset Management (Hong Kong) Ltd.as of 31 Oct 202514.65m1.30%
Fidelity Management & Research Co. LLCas of 31 Dec 202510.58m0.94%
BlackRock Fund Advisorsas of 06 Feb 20268.91m0.79%
Guotai Asset Management Co., Ltd.as of 30 Jun 20258.68m0.77%
�KOWORLD LUX SAas of 30 Jun 20258.25m0.73%
Fiera Capital (UK) Ltd.as of 31 Oct 20257.68m0.68%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.